VistaGen Therapeutics (VTGN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

VTGN is expected to report earnings to fall 94.68% to -5 cents per share on June 27

VistaGen Therapeutics VTGN Stock Earnings Reports

Q1'23

Est.

$-0.05

Q2'23

Beat

by $1.31

Q4'22

Beat

by $0.02

Q3'22

Missed

by $0.01

Q2'22

Missed

by $0.02

The last earnings report on August 10 showed earnings per share of -93 cents, beating the estimate of -225 cents. With 57.65K shares outstanding, the current market capitalization sits at 83.06M.

View a ticker or compare two or three

Compare

VTGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VTGN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

343 Allerton Avenue

Phone

+1 650 577-3600

Employees

Web

https://www.vistagen.com